Aranesp (darbepoetin alfa) is an injectable medication used to treat low red blood cell count (anemia). It's long-acting and doesn't have to be given as often as similar medications. About one-third of people who take Aranesp (darbepoetin alfa) may experience high blood pressure as a side effect. There are other serious risks with this medication, especially if you have certain types of cancer, so make sure your entire healthcare team knows your full medical history.
Anemia due to chemotherapy
Anemia due to chronic kidney disease (dialysis and non-dialysis)
Aranesp (darbepoetin alfa) is an erythropoiesis-stimulating agent (ESA). It works similarly to a naturally-occurring hormone in our body (erythropoietin). Erythropoietin sends a signal to our body to make more red blood cells.
Source:Â DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Accumulation of pus
arm, back, or jaw pain
blurred vision
breathing problems (irregular, noisy, or trouble when resting)
chest pain, discomfort, tightness, or heaviness
chills
confusion
cough producing mucus
decrease in the amount of urine
dilated neck veins
dizziness, fainting, or lightheadedness
fast, slow, or irregular heartbeat
fatigue or tiredness (extreme or unusual)
headache
pain, tenderness, swelling, or warmth over the injection site
pounding in the ears
rapid breathing
rapid or pounding pulse
skin discoloration at the injection site
stomach pain
sunken eyes
sweating
swelling of the ankles, face, fingers, feet, hands, or lower legs
thirst
trouble with breathing
unconsciousness
vomiting
wrinkled skin
Less common
difficulty with speaking (slow speech or unable to speak)
double vision
seizures
trouble with thinking
trouble with walking
unable to move the arms, legs, or face muscles (including numbness and tingling)
Incidence not known
Blistering, peeling, or loosening of the skin
joint or muscle pain
red, irritated eyes
red skin lesions, often with a purple center
sores, ulcers, or white spots in mouth or on the lips
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
general feeling of discomfort or illness
lack or loss of strength
loss of appetite
muscle aches, pains, or stiffness
shivering
trouble with sleeping
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Long-lasting so it doesn't have to be injected as often as some similar medications
Can be injected at home in certain situations and comes as a prefilled "SingleJect" syringe for easier administration
Doesn't contain albumin, so it's less likely to cause an allergic reaction
Can raise the risk of blood clots and other heart-related conditions
No lower-cost generic available
Only works if you have enough iron in your blood
No proof that Aranesp (darbepoetin alfa) can improve quality of life, fatigue, or well-being
Talk to your provider if you have a history of heart or blood clotting problems. ESA medications like Aranesp (darbepoetin alfa) can raise your risk of blood clots and lead to heart attacks or stroke. Report any chest pain, breathing problems, or confusion to your provider right away.
Aranesp (darbepoetin alfa) can raise your blood pressure. Monitor your blood pressure as directed and take blood pressure-lowering medications as prescribed.
Store Aranesp (darbepoetin alfa) in the refrigerator (not in the freezer). Keep it in its original carton to protect it from light. Don't shake it.
Always inspect the medication before you prepare your injection. Make sure it's not cloudy, leaky, or containing any particles (solid chunks). If it has particles, is discolored, or foamy, don't use it. Instead, contact your provider or pharmacy about getting a replacement.
Injection instructions will differ from person to person and some people on dialysis might have a port they can administer the medication through. Make sure you understand how to inject the medication properly before starting home injections. It's important to get the correct amount of medication.
Throw away your needles, syringes, and leftover medication after each use. The vials and syringes are made for single-use and improper use can lead to serious infections.
Aranesp (darbepoetin alfa) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: History of heart disease | Uncontrolled high blood pressure | High red blood cell level
Studies found that Aranesp (darbepoetin alfa) can raise the risk of death and serious heart conditions, such as a heart attack or stroke. The risk is higher in people with a history of heart-related conditions and those with higher levels of hemoglobin (a protein found in red blood cells). Make sure you have your labs drawn regularly so your provider can monitor your body's response.
Aranesp (darbepoetin alfa) can lower the amount of blood transfusions needed, but can also lead to more tumor growth and overall shortened survival. To lower this risk, Aranesp (darbepoetin alfa) should only be used in certain situations and may not be a good option for people with certain curable cancers.
Aranesp (darbepoetin alfa) can raise blood pressure and shouldn't be used in people who have uncontrolled high blood pressure. Aranesp (darbepoetin alfa) can be used once your blood pressure is controlled and it's important that you continue the medication and dietary changes that lowered your blood pressure. If your blood pressure becomes too high after starting Aranesp (darbepoetin alfa) your provider might pause the medication or lower your dose. They can also add more blood pressure-lowering medications.
Aranesp (darbepoetin alfa) can raise the risk of having a seizure in people with CKD. Your provider will monitor this closely during the first few months. Contact your provider if you do have a seizure and report any pre-seizure symptoms such as a migraine or sensitivity to light or sound.
Risk factors: Low iron levels | Bleeding | Infection | Inflammation
Sometimes Aranesp (darbepoetin alfa) doesn't work or stops working after a while. If your anemia doesn't respond to the medication, your provider will evaluate potential factors that might be the cause. One possible reason is having low iron levels, so it's important to take iron supplements if prescribed or directed.
Though rare, Aranesp (darbepoetin alfa) can cause serious allergic reactions or skin reactions (Stevens-Johnson Syndrome). Let your provider know right away if you experience symptoms such as trouble breathing, skin rash, welts, and peeling or blistering skin.
Your provider will determine your dose based on factors such as your body weight, age, and hemoglobin level.
Anemia due to chemotherapy
The typical starting dose is 2.25 mcg/kg injected under the skin every week, or 500 mcg every 3 weeks until chemotherapy is finished.
Anemia due to CKD
Adults (not receiving dialysis): The typical recommended starting dose is 0.45 mcg/kg body weight injected under the skin or through the veins once every 4 weeks.
Adults (receiving dialysis): The typical recommended starting dose is 0.45 mcg/kg body weight injected under the skin or through the veins once a week, or 0.75 mcg/kg injected once every 2 weeks.
Children: The typical recommended starting dose is 0.45 mcg/kg body weight injected under the skin or through the veins once a week. If not receiving dialysis, the usual starting dose is 0.75 mcg/kg injected once every 2 weeks.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
High blood pressure that's not controlled
Pure red cell aplasia (PRCA) that begins after treatment with ESAs
Anemia due to chemotherapy
Anemia due to chronic kidney disease (dialysis and non-dialysis)
Treatment of anemia due to chemotherapy, chronic kidney disease, and zidovudine use in HIV-infected patients
Reduction of allogeneic red blood cell transfusions in patients having elective, noncardiac, nonvascular surgery
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
American Cancer Society. (2023). Low red blood cell counts (anemia).
Amgen Inc. (2012). Instructions for use.
Amgen Inc. (2018). Aranesp- darbepoetin alfa injection, solution; darbepoetin alfa solution [package insert]. DailyMed.Â
Mangla, A., et al. (2022). Pure red cell aplasia. StatPearls.
National Cancer Institute. (n.d.). Hemoglobin.
Schoener, B., et al. (2023). Erythropoietin stimulating agents. StatPearls.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.